How has Indivior Pharmaceuticals, Inc. 's net investment in lease changed year-over-year?

Indivior Pharmaceuticals, Inc. 's net investment in lease decreased by 40.5% year-over-year, from $37M to $22M.

What is the long-term trend for Indivior Pharmaceuticals, Inc. 's net investment in lease?

Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's net investment in lease has grown at a -19.4% compound annual growth rate (CAGR), from $40M to $26M.

Indivior Pharmaceuticals, Inc. INDV Net Investment in Lease

Net Investment in Lease at other companies

AlkermesALKS

——

JAN

Janus Living JAN

——

Other financials

Income statement

See full

Revenue$317.0M+19.2%

Gross profit$277.0M+24.8%

Operating income$137.0M+108%

Net income$89.0M+89.4%

EPS (diluted)$0.69+81.6%

Balance sheet

See full

Cash & equivalents$175.0M-53.0%

Total debt$509.0M+37.6%

Total equity-$144.0M+49.5%

Total assets$1.2B-12.9%

Cash flow

See full

Operating cash flow-$9.0M-112%

CapEx$20.0M+300%

Free cash flow-$29.0M-141%

Valuation

See full

Market cap$4.53B+213%

Profitability

See full

Gross margin81.3%+1.5pp

Operating margin25.8%+23.3pp

Net margin19.4%+18.9pp

FCF margin-14.9%—

Returns & leverage

See full

Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's net investment in lease?: Indivior Pharmaceuticals, Inc. (INDV) reported net investment in lease of $22M in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's net investment in lease changed year-over-year?: Indivior Pharmaceuticals, Inc. 's net investment in lease decreased by 40.5% year-over-year, from $37M to $22M.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's net investment in lease?: Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's net investment in lease has grown at a -19.4% compound annual growth rate (CAGR), from $40M to $26M.